FI3759249T3 - Nukleosomimodifikaatioiden kvantitointi kemiallisesti määriteltyjä rekombinanttisia nukleosomeja käyttäen - Google Patents

Nukleosomimodifikaatioiden kvantitointi kemiallisesti määriteltyjä rekombinanttisia nukleosomeja käyttäen Download PDF

Info

Publication number
FI3759249T3
FI3759249T3 FIEP19760658.5T FI19760658T FI3759249T3 FI 3759249 T3 FI3759249 T3 FI 3759249T3 FI 19760658 T FI19760658 T FI 19760658T FI 3759249 T3 FI3759249 T3 FI 3759249T3
Authority
FI
Finland
Prior art keywords
nucleosomes
nucleosome
histone
biological sample
modification
Prior art date
Application number
FIEP19760658.5T
Other languages
English (en)
Finnish (fi)
Inventor
Martis William Cowles
Matthew F Whelihan
Andrea L Johnstone
Michael-Christopher Keogh
Zu-Wen Sun
Nathan W Hall
Matthew R Marunde
Original Assignee
Epicypher Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epicypher Inc filed Critical Epicypher Inc
Application granted granted Critical
Publication of FI3759249T3 publication Critical patent/FI3759249T3/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/31—Endoribonucleases active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters (3.1.31)
    • C12Y301/31001—Micrococcal nuclease (3.1.31.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material
    • G01N2440/18—Post-translational modifications [PTMs] in chemical analysis of biological material citrullination

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Ecology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FIEP19760658.5T 2018-03-01 2019-03-01 Nukleosomimodifikaatioiden kvantitointi kemiallisesti määriteltyjä rekombinanttisia nukleosomeja käyttäen FI3759249T3 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862637066P 2018-03-01 2018-03-01
PCT/US2019/020283 WO2019169263A1 (en) 2018-03-01 2019-03-01 Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes

Publications (1)

Publication Number Publication Date
FI3759249T3 true FI3759249T3 (fi) 2023-10-11

Family

ID=67805943

Family Applications (2)

Application Number Title Priority Date Filing Date
FIEP19760658.5T FI3759249T3 (fi) 2018-03-01 2019-03-01 Nukleosomimodifikaatioiden kvantitointi kemiallisesti määriteltyjä rekombinanttisia nukleosomeja käyttäen
FIEP23157465.8T FI4215621T3 (fi) 2018-03-01 2019-03-01 Nukleosomimodifikaatioiden kvantifiointi kemiallisesti määriteltyjä rekombinanttinukleosomeja käyttämällä

Family Applications After (1)

Application Number Title Priority Date Filing Date
FIEP23157465.8T FI4215621T3 (fi) 2018-03-01 2019-03-01 Nukleosomimodifikaatioiden kvantifiointi kemiallisesti määriteltyjä rekombinanttinukleosomeja käyttämällä

Country Status (10)

Country Link
US (2) US10787697B2 (cg-RX-API-DMAC7.html)
EP (2) EP3759249B1 (cg-RX-API-DMAC7.html)
JP (1) JP7376493B2 (cg-RX-API-DMAC7.html)
CN (1) CN111918971B (cg-RX-API-DMAC7.html)
AU (1) AU2019228625B2 (cg-RX-API-DMAC7.html)
CA (1) CA3091807A1 (cg-RX-API-DMAC7.html)
DK (2) DK4215621T3 (cg-RX-API-DMAC7.html)
ES (2) ES2960550T3 (cg-RX-API-DMAC7.html)
FI (2) FI3759249T3 (cg-RX-API-DMAC7.html)
WO (1) WO2019169263A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230003735A1 (en) * 2019-12-02 2023-01-05 Belgian Volition Srl Use of cell free nucleosomes as biomarkers
US12636417B2 (en) 2020-09-21 2026-05-26 Belgian Volition Srl Device for inline monitoring of free nucleosomes in blood
CN112359092B (zh) * 2020-10-22 2023-09-19 中国农业科学院农业基因组研究所 一种基因组短片段文库的构建方法
CA3195344A1 (en) * 2020-11-02 2022-05-05 Matthew R. MARUNDE Improved assays to quantify chromatin targets using antibody-targeted enzyme digestion
GB202108185D0 (en) * 2021-06-08 2021-07-21 Belgian Volition Sprl Standardisation of nucleosome assays using biologically derived calibrants
WO2023159045A1 (en) * 2022-02-15 2023-08-24 Epicypher, Inc. Engineered recombinant protein-binding domains as detection reagents
WO2024042208A1 (en) * 2022-08-25 2024-02-29 Belgian Volition Srl Method for the detection of dementia
EP4602370A1 (en) * 2022-10-12 2025-08-20 Epicypher, Inc. High efficiency antibodies for chromatin targets
EP4639173A1 (en) * 2022-12-19 2025-10-29 Belgian Volition SRL Calibration
EP4689160A1 (en) * 2023-04-03 2026-02-11 Belgian Volition SRL Recombinant nucleosome materials

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1008748A (en) 1910-06-15 1911-11-14 Christian Keene Snavely Shade-roller.
GB0319376D0 (en) * 2003-08-18 2003-09-17 Chroma Therapeutics Ltd Histone modification detection
WO2011016869A1 (en) 2009-08-06 2011-02-10 Kamran Tahamtanzadeh Methods and compositions for drug discovery
EP2621942A4 (en) * 2010-09-29 2015-01-21 Gen Hospital Corp MEANS FOR PROVIDING CONTROLS AND STANDARDS FOR IMMUNE PRECIPITATION ASSAYS
GB201115099D0 (en) 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes
GB201115095D0 (en) * 2011-09-01 2011-10-19 Singapore Volition Pte Ltd Method for detecting nucleosomes containing nucleotides
GB201115098D0 (en) * 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes containing histone variants
EP2859139B1 (en) 2012-06-06 2018-08-01 The Trustees Of Princeton University Dna barcoding of designer mononucleosome and chromatin array libraries for the profiling of chromatin readers, writers, erasers, and modulators thereof
US9745384B2 (en) * 2012-12-20 2017-08-29 The Brigham And Women's Hospital, Inc. Peptides useful for modulating histone demethylase function
GB201303575D0 (en) * 2013-02-28 2013-04-10 Singapore Volition Pte Ltd Method for detecting histone modifications in nucleosomes
GB201400522D0 (en) * 2014-01-13 2014-02-26 Proteros Biostructure Gmbh Nucleosome substrate assays
EP3102721B1 (en) * 2014-02-03 2020-04-15 The University of Chicago Compositions and methods for quantitative assesment of dna-protein complex density
GB201511512D0 (en) 2015-07-01 2015-08-12 Singapore Volition Pte Ltd Use of cell-free nucleosomes as biomarkers
WO2017034970A1 (en) * 2015-08-21 2017-03-02 The General Hospital Corporation Combinatorial single molecule analysis of chromatin
GB201518665D0 (en) * 2015-10-21 2015-12-02 Singapore Volition Pte Ltd Method for enrichment of cell free nucleosomes
EP3371601A1 (en) 2015-11-05 2018-09-12 Epizyme Inc Flow cytometry for monitoring histone h3 methylation status

Also Published As

Publication number Publication date
US10787697B2 (en) 2020-09-29
DK4215621T3 (da) 2025-08-04
JP2021515888A (ja) 2021-06-24
CN111918971A (zh) 2020-11-10
EP4215621A1 (en) 2023-07-26
CA3091807A1 (en) 2019-09-06
EP3759249B1 (en) 2023-08-30
ES3036655T3 (en) 2025-09-23
CN111918971B (zh) 2024-09-03
EP4215621B1 (en) 2025-05-28
US20200071745A1 (en) 2020-03-05
ES2960550T3 (es) 2024-03-05
AU2019228625A1 (en) 2020-09-03
US20210010058A1 (en) 2021-01-14
FI4215621T3 (fi) 2025-07-28
EP3759249A1 (en) 2021-01-06
US12104199B2 (en) 2024-10-01
DK3759249T3 (da) 2023-10-30
JP7376493B2 (ja) 2023-11-08
WO2019169263A1 (en) 2019-09-06
AU2019228625B2 (en) 2024-11-07
EP3759249A4 (en) 2021-11-24

Similar Documents

Publication Publication Date Title
Blue et al. Transcriptome-wide identification of RNA-binding protein binding sites using seCLIP-seq
FI4215621T3 (fi) Nukleosomimodifikaatioiden kvantifiointi kemiallisesti määriteltyjä rekombinanttinukleosomeja käyttämällä
Edfors et al. Gene‐specific correlation of RNA and protein levels in human cells and tissues
Xie et al. The intriguing landscape of single‐cell protein analysis
Budayeva et al. A mass spectrometry view of stable and transient protein interactions
CN107002289B (zh) 用于定量评价dna-蛋白质复合物密度的组合物和方法
JP6687618B2 (ja) 組換えタンパク質調製物中の残留宿主細胞タンパク質の検出
US20210095348A1 (en) Methods and systems to perform genetically variant protein analysis, and related marker genetic protein variations and databases
Ayoglu et al. Systematic antibody and antigen-based proteomic profiling with microarrays
Bomans et al. Identification and monitoring of host cell proteins by mass spectrometry combined with high performance immunochemistry testing
Yazaki et al. HaloTag-based conjugation of proteins to barcoding-oligonucleotides
Hung et al. Microfluidic platforms for discovery and detection of molecular biomarkers
WO2022094449A1 (en) Improved assays to quantify chromatin targets using antibody-targeted enzyme digestion
EP3465205A1 (en) Antibody validation using ip-mass spectrometry
WO2015122835A1 (en) Method for protein analysis
US20180172683A1 (en) Methods for analyzing the interaction between a target protein and a ligand
CN106233144A (zh) 使用热移位测定用于鉴定指示药物应答减少的生物标记物的方法
Spisak et al. Biomedical applications of protein microarrays
Aziz et al. Autoantibody-based diagnostic biomarkers: Technological approaches to discovery and validation
EP4669770A1 (en) SEQUENCE PROCESSES FOR POLYPEPTIDES AND ASSOCIATED COMPONENTS
Treitz et al. Combination of a SAW-biosensor with MALDI mass spectrometric analysis
US20150148243A1 (en) Method for reversible fixation or selective lysis of cell using photocleavable polymer
WO2017059239A1 (en) Methods for processing biopolymeric arrays
CN102713624B (zh) 抗Ku86自身抗体的免疫测定方法、其中使用的试剂盒、及使用其的原发性肝细胞癌的判断方法
CN107219369B (zh) 避免信号干扰的肌原纤维蛋白丝氨酸磷酸化水平的测定方法